Home
>
National Drug Code (NDC)
>
Sandimmune
Sandimmune - 0078-0240-15 - (cyclosporine)
Drug Information of Sandimmune
| Product NDC: | 0078-0240 |
| Proprietary Name: | Sandimmune |
| Non Proprietary Name: | cyclosporine |
| Active Ingredient(s): | 25 mg/1 & nbsp; cyclosporine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sandimmune
| Product NDC: | 0078-0240 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050625 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19900302 |
Package Information of Sandimmune
| Package NDC: | 0078-0240-15 |
| Package Description: | 30 BLISTER PACK in 1 PACKAGE (0078-0240-15) > 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0240-61) |
NDC Information of Sandimmune
| NDC Code | 0078-0240-15 |
| Proprietary Name | Sandimmune |
| Package Description | 30 BLISTER PACK in 1 PACKAGE (0078-0240-15) > 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0240-61) |
| Product NDC | 0078-0240 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cyclosporine |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 19900302 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | CYCLOSPORINE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
